Literature DB >> 35715519

Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).

Zhiqing Hu1, Pengchong Xu1, Eman A Ashour1, Michael A Repka2,3.   

Abstract

Amorphous solid dispersion (ASD) has been well known as a potential strategy to improve the bioavailability and dissolution performance of poorly water-soluble drugs. The primary concern of this approach is the long-term stability of the amorphous drug in the solid dispersion. Accurate prediction and detection of the solubility and miscibility of drug in polymeric binary system will be a milestone to the development of ASDs. In this investigation, a method based on Flory-Huggins (F-H) theory was proposed to predict and calculate the solubility and miscibility of the drug in polymeric matrix and construct the phase diagram to identify the relevance between drug loading and temperature for ASDs development. Indomethacin (Indo) was chosen as the model drug, and polyvinyl pyrrolidone vinyl acetate (Kollidon® VA 64) was used as a polymeric carrier for the ASD systems. Physical mixtures were prepared with different drug loadings (10 to 90%) and analyzed by differential scanning calorimetry (DSC). The interaction parameter χ was calculated for physical mixtures by the melting point depression and solubility parameter contribution methods. The phase diagram was constructed to investigate the impact of other parameters like drug loading, processing temperature, and Gibbs free energy of mixing (ΔGmix). For further validation, formulations were developed using HME to verify the accuracy of the phase diagram and to guide in the hot-melt extrusion (HME) process design space and optimization.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  amorphous solid dispersions; flory–huggins theory; formulation; hot-melt extrusion; melting point depression; miscibility; phase diagram

Mesh:

Substances:

Year:  2022        PMID: 35715519     DOI: 10.1208/s12249-022-02319-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  27 in total

Review 1.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Authors:  A T Serajuddin
Journal:  J Pharm Sci       Date:  1999-10       Impact factor: 3.534

Review 2.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

Review 3.  Improving drug solubility for oral delivery using solid dispersions.

Authors:  C Leuner; J Dressman
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

4.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

5.  Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.

Authors:  Anant Shanbhag; Shelley Rabel; Ewa Nauka; Gemma Casadevall; Padmaja Shivanand; Gary Eichenbaum; Paul Mansky
Journal:  Int J Pharm       Date:  2007-10-09       Impact factor: 5.875

Review 6.  Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.

Authors:  Teófilo Vasconcelos; Bruno Sarmento; Paulo Costa
Journal:  Drug Discov Today       Date:  2007-10-30       Impact factor: 7.851

Review 7.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

Authors:  Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

8.  Selection of oral bioavailability enhancing formulations during drug discovery.

Authors:  Weijia Zheng; Akash Jain; Dimitris Papoutsakis; Rose-Marie Dannenfelser; Riccardo Panicucci; Sudhakar Garad
Journal:  Drug Dev Ind Pharm       Date:  2011-08-19       Impact factor: 3.225

9.  An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations.

Authors:  Osama A Abu-Diak; David S Jones; Gavin P Andrews
Journal:  Mol Pharm       Date:  2011-07-01       Impact factor: 4.939

Review 10.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.